Trials / Completed
CompletedNCT00201955
Study of Rebamipide Eye Drops to Treat Dry Eye
Rebamipide Ophthalmic Suspension in the Treatment of Dry Eye: A Multicenter, Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, 26 Week Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 740 (planned)
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the potential safety and effectiveness of rebamipide eye drops, an investigational eye drop being developed for the treatment of keratoconjunctivitis sicca (dry eye).
Detailed description
There is a need for effective therapy for dry eye that treats the underlying cause of the syndrome. The goal of this study is to assess the impact of rebamipide on dry eye symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rebamipide |
Timeline
- Start date
- 2004-05-01
- Completion
- 2006-07-01
- First posted
- 2005-09-20
- Last updated
- 2006-11-02
Locations
60 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00201955. Inclusion in this directory is not an endorsement.